ReviewActa pharmaceutica Sinica. B2023

Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition.

Yaochen Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.